Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3681551013 | Acetaminophen 325 mg and dichloralphenazone 100 mg and isometheptene 65 mg oral capsule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3681552018 | Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3681553011 | Dichloralphenazone 100 mg and isometheptene 65 mg and paracetamol 325 mg oral capsule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4722311000005110 | paracetamol 325 mg + dichloralantipyrin 100 mg+ isomethepten 65 mg, kapsel | da | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | dansk modul |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Product containing isometheptene (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Isometheptene (substance) | false | Inferred relationship | Some | ||
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Product containing dichloralphenazone and isometheptene and paracetamol (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Non-opioid analgesic (substance) | false | Inferred relationship | Some | ||
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Paracetamol | false | Inferred relationship | Some | ||
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has manufactured dose form | Capsule | false | Inferred relationship | Some | ||
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Dichloralphenazone (substance) | false | Inferred relationship | Some | ||
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Sedative (substance) | false | Inferred relationship | Some | ||
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has manufactured dose form | Oral capsule | true | Inferred relationship | Some | ||
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Isometheptene-containing product in oral dose form | false | Inferred relationship | Some | ||
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Product containing paracetamol in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Paracetamol | false | Inferred relationship | Some | 1 | |
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Paracetamol | false | Inferred relationship | Some | 1 | |
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value | 325 | false | Inferred relationship | Some | 1 | |
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator value | en | false | Inferred relationship | Some | 1 | |
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator value | en | false | Inferred relationship | Some | 2 | |
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | true | Inferred relationship | Some | 2 | |
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Dichloralphenazone (substance) | false | Inferred relationship | Some | 3 | |
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value | 100 | false | Inferred relationship | Some | 3 | |
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 3 | |
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator value | en | false | Inferred relationship | Some | 3 | |
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | true | Inferred relationship | Some | 3 | |
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Isometheptene (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value | 65 | false | Inferred relationship | Some | 1 | |
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Dichloralphenazone (substance) | false | Inferred relationship | Some | 2 | |
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Dichloralphenazone (substance) | false | Inferred relationship | Some | 2 | |
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value | 100 | false | Inferred relationship | Some | 2 | |
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Isometheptene (substance) | false | Inferred relationship | Some | 3 | |
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Isometheptene (substance) | false | Inferred relationship | Some | 3 | |
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value | 65 | false | Inferred relationship | Some | 3 | |
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Paracetamol | false | Inferred relationship | Some | 2 | |
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value | 325 | false | Inferred relationship | Some | 2 | |
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Paracetamol | false | Inferred relationship | Some | 2 | |
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | Capsule (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Isometheptene (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Dichloralphenazone (substance) | false | Inferred relationship | Some | 3 | |
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Count of base of active ingredient | tre | false | Inferred relationship | Some | ||
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Dichloralphenazone and isometheptene and paracetamol only product in oral dose form | true | Inferred relationship | Some | ||
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Isometheptene (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Dichloralphenazone (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Dichloralphenazone (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Paracetamol | true | Inferred relationship | Some | 3 | |
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Paracetamol | true | Inferred relationship | Some | 3 | |
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Isometheptene (substance) | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR